PotomacRiver
  • Company
    • Our Story
    • Our Team
    • Our Location
    • FAQ
  • Our Solutions
    • Policies & Procedures
    • Learning & Engagement
    • Auditing & Monitoring
    • Transparency Reporting
    • Operational Excellence
  • Careers
    • What We Do
    • Why Potomac?
    • Current Openings
    • Interview Process
    • Frequently Asked Questions
  • Potomac Thinking
    • Year-in-Review
    • Currents
    • Presentations
    • Brochures
    • Conferences
    • Industry Resources
  • Contact

Potomac Thinking

Industry Resources

Laws and Regulations

  • Enforcement of the Drug Sample Distribution Requirements of the Prescription Drug Marketing Act (PDMA)
  • Federal Anti-Kickback Statute (AKS)
  • Federal Acquisition Regulation (FAR)
  • False Claims Act (FCA)
  • Federal Food, Drug and Cosmetic Act (FDCA)
  • FDA Amendments Act (FDAAA)
  • Foreign Corrupt Practices Act (FCPA)
  • Health Insurance Portability and Accountability Act (HIPAA)
  • Health Information Technology for Economic and Clinical Health Act (HITECH)
  • Patient Protection and Affordable Care Act (PPACA)
  • Prescription Drug Marketing Act (PDMA)
  • Sunshine Act
  • Sunshine Act Final Rule
  • UK Bribery Act

Codes

  • PhRMA Code on Interactions with Healthcare Professionals
  • Statement on Application of Section 2 of PhRMA Code during Emergency Periods
  • PhRMA Conduct of Clinical Trials
  • PhRMA Guiding Principles for DTC Advertisements
  • PhRMA Principles on Interactions with Patient Organizations
  • AdvaMed Code of Ethics
  • MDMA Code of Conduct on Interactions with Healthcare Professionals
  • EFPIA Code of Practice
  • Standards for Integrity and Independence in Accredited Continuing Education

Guidance

  • OIG General Compliance Program Guidance (November 2023)
  • OIG Special Fraud Alert: Speaker Programs (November 2020)
  • DOJ Guidance on Compliance (June 2020)
  • Internet/Social Media Platforms: Correcting Independent Third-Party Misinformation About Prescription Drugs and Medical Devices
  • OIG Compliance Program Guidance (January 2017)
  • OIG Advisory on Patient Travel & Lodging
  • DOJ/SEC FCPA Resource Guide
  • OIG PDMA Guidance
  • FDA PDMA COVID-19 Guidance
  • IFPMA Note for Guidance on Patient and Patient Organization Interactions

Year in Review





    Year in Review Webinar





      Presentation Download





        PotomacRiver

        1911 N. Fort Myer Dr. Suite 701
        Arlington, VA 22209
        703.430.5944

        • Company
          • Our Story
          • Our Team
          • Our Location
          • FAQ
        • Our Solutions
          • Policies & Procedures
          • Learning & Engagement
          • Auditing & Monitoring
          • Transparency Reporting
          • Operational Excellence
        • Careers
          • What We Do
          • Why Potomac?
          • Current Openings
          • Interview Process
          • Frequently Asked Questions
        • Potomac Thinking
          • Year-in-Review
          • Currents
          • Presentations
          • Brochures
          • Conferences
          • Industry Resources
        • Contact
        © 2026 All Rights Reserved, Potomac River Partners

        Website by LightMix